journal article·2024-11-11

Fresh Human Umbilical Cord Arteries as a Potential Source for Small-Diameter Vascular Grafts

Trung-Chuc Nguyen, Toan Linh Nguyen, Xuan-Hung Nguyen, Khac-Cuong Bui, Tuan-Anh Pham, Linh Dieu Do, Nghia Trung Tran, Thanh-Liem Nguyen, Nhung Thi My Hoang, Xuan-Hai Do

Publisher page

Abstract

The demand for small-diameter vascular grafts has been globally increased but still lacks optimal solutions in this category. This study evaluated the feasibility of utilizing human pretreated fresh and nondecellularized umbilical cord arteries (hUCAs) as vascular grafts without needing any immunosuppression process. A mixed lymphocyte reaction assay revealed that hUCAs did not induce lymphocyte proliferation or cytokine production. To assess the in vivo inflammatory response, hUCAs were buried in fatty tissue under the skin of the abdominal wall in the left and right iliac fossas of rats. The average sizes of the implanted hUCAs remained consistent at 30 days post implantation. To evaluate xenogeneic transplantation, hUCAs were grafted to the abdominal aorta below the kidney of Wister rats. Remarkably, all rats exhibited positive revascularization and perfusion, maintaining blood pressure values of around 110/70 mmHg. Doppler ultrasound consistently indicated good circulation, with the three separate echogenic layers corresponding to the three arterial wall layers throughout the assessment period. Grafted rats exhibited normal motor behavior, accompanied by positive responses to thermal and pain stimulation. Blood biochemical values and whole blood cell counts showed no significant differences between pre and post-transplantation. Histological analysis of the grafts revealed no calcification or thrombosis, and a mild chronic inflammatory response was presented. In conclusion, hUCAs maintained their structural and functional properties after transplantation in rats without immunosuppression. This highlights their potential as a source for allogeneic, readily accessible, small-diameter vascular grafts.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Practical and Experimental Surgery, Vietnam Military Medical University, 160 Phung Hung Street, Phuc La, Ha Dong, Hanoi 10000, Vietnam

Department of Pathophysiology, Vietnam Military Medical University, 160 Phung Hung Street, Phuc La, Ha Dong, Hanoi 10000, Vietnam

Vinmec Hi-Tech Center, Vinmec Healthcare System, 458 Minh Khai Street, Hanoi 10000, Vietnam

College of Health Sciences

VinUniversity

Faculty of Biology, VNU University of Science, 334 Nguyen Trai Street, Thanh Xuan, Hanoi 10000, Vietnam

Vinmec Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, 458 Minh Khai Street, Hanoi 10000, Vietnam

Funding

Qu? ??i m?i s?ng t?o Vingroup

References (40)

Show source-provided references
1. World Health Organization (WHO). Cardiovascular Diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
2. World Health Organization (WHO). Cardiovascular Diseases (CVD) in Viet Nam. https://www.who.int/vietnam/health-topics/cardiovascular-diseases.
3. 10.1161/CIR.000000000000048510.1161/CIR.0000000000000485 ↗
4. 10.1038/ncpcardio093010.1038/ncpcardio0930 ↗
5. 10.1016/S2214-109X(20)30117-010.1016/S2214-109X(20)30117-0 ↗
6. 10.52604/alt.21.001610.52604/alt.21.0016 ↗
7. 10.1186/s13019-017-0661-x10.1186/s13019-017-0661-x ↗
8. 10.1016/j.addr.2011.03.00110.1016/j.addr.2011.03.001 ↗
9. 10.3389/fcvm.2020.59236110.3389/fcvm.2020.592361 ↗
10. Sapehia D. · 2021 · 11710.1016/B978-0-12-819753-0.00007-6 ↗
11. 10.1016/j.jvs.2004.03.03310.1016/j.jvs.2004.03.033 ↗
12. 10.1152/ajpheart.00564.200410.1152/ajpheart.00564.2004 ↗
13. 10.1073/pnas.101950610810.1073/pnas.1019506108 ↗
14. 10.1089/ten.tea.2008.052610.1089/ten.tea.2008.0526 ↗
15. 10.1089/ten.2006.012110.1089/ten.2006.0121 ↗
16. 10.3171/jns.1984.61.4.073710.3171/jns.1984.61.4.0737 ↗
17. 10.1097/01.MAT.0000160872.41871.7E10.1097/01.MAT.0000160872.41871.7E ↗
18. 10.1097/MAT.000000000000071510.1097/MAT.0000000000000715 ↗
19. 10.1007/s12257-022-0256-910.1007/s12257-022-0256-9 ↗
20. 10.3390/cells1108133910.3390/cells11081339 ↗
21. 10.1016/j.jcyt.2021.02.10910.1016/j.jcyt.2021.02.109 ↗
22. 10.3727/096368910X53647310.3727/096368910X536473 ↗
23. 10.3390/bioengineering1001011010.3390/bioengineering10010110 ↗
24. 10.3390/ijms2215798110.3390/ijms22157981 ↗
25. 10.1186/s13287-021-02694-y10.1186/s13287-021-02694-y ↗
26. 10.3390/bioengineering704016010.3390/bioengineering7040160 ↗
27. 10.1002/term.300410.1002/term.3004 ↗
28. 10.3390/ijms2310533710.3390/ijms23105337 ↗
29. 10.1097/TP.000000000000106410.1097/TP.0000000000001064 ↗
30. 10.3389/fimmu.2020.59460910.3389/fimmu.2020.594609 ↗
31. 10.1089/ten.teb.2019.022910.1089/ten.teb.2019.0229 ↗
32. Morris A. H. · 2017 · 72
33. 10.1016/j.biomaterials.2006.06.02010.1016/j.biomaterials.2006.06.020 ↗
34. 10.1146/annurev-immunol-071719-09490310.1146/annurev-immunol-071719-094903 ↗
35. 10.1155/2015/63138410.1155/2015/631384 ↗
36. 10.3390/ijms1911352810.3390/ijms19113528 ↗
37. 10.3390/ijms1711182310.3390/ijms17111823 ↗
38. 10.3389/fimmu.2017.0066710.3389/fimmu.2017.00667 ↗
39. 10.4049/jimmunol.150011710.4049/jimmunol.1500117 ↗
40. 10.1016/j.actbio.2008.11.02810.1016/j.actbio.2008.11.028 ↗